INCIPOD-CV 325
Composition
Cefpodoxime Proxetil 200mg + Potassium Clavulanate 125mg Tablet
Indication
InciPod CV 325 tablets, containing Cefpodoxime Proxetil (200mg) and Potassium Clavulanate (125mg), are a potent treatment for respiratory tract infections. This combination leverages the antibacterial efficacy of Cefpodoxime Proxetil and the beta-lactamase inhibiting properties of Clavulanic Acid. Cefpodoxime Proxetil disrupts bacterial cell wall synthesis, crucial for bacterial survival, while Clavulanic Acid prevents the breakdown of the antibiotic by beta-lactamase enzymes, thereby enhancing its effectiveness against a broad spectrum of bacteria.
InciPod CV 325 tablets are specially formulated to effectively treat infections such as bronchitis, pneumonia, and sinusitis. By inhibiting bacterial resistance mechanisms, they promote faster recovery and help prevent complications related to respiratory infections. These tablets are developed by trusted pharmaceutical companies dedicated to maintaining high standards of quality and patient care.
The synergy between Cefpodoxime Proxetil and Potassium Clavulanate in InciPod CV 325 tablets underscores their role as a reliable treatment option, addressing both bacterial diversity and resistance challenges in respiratory tract infections. This combination not only targets pathogens effectively but also helps mitigate the risk of antibiotic resistance, making it a preferred choice among healthcare providers for managing respiratory infections comprehensively.
Contraindication
Nausea, Diarrhoea, Headache, Rash, Abdominal pain, vaginal infection, fungal infection of vaginaStorage
Cool & Dry Place
Inquire Now